GlassScriptPhysician profile
Huy D Hoang
NPI 1376975185
$27,146.47
in general payments reported to CMS, 2019-2025
11 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $316 · 2021: $2,771 · 2022: $473 · 2023: $22K · 2024: $1,408 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Food and Beverage: $2,917 · Travel and Lodging: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,500.00 |
| Food and Beverage | $2,917.27 |
| Travel and Lodging | $169.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,353.38 | 2020-2024 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $3,444.33 | 2021-2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Seamguard |
| Medtronic, INC. | $653.81 | 2023-2025 | Ligasure, Signia |
| Ethicon US, LLC | $568.27 | 2020-2023 | Vistaseal, Dermabond Prineo, Prolene |
| Davol INC. | $333.00 | 2023-2025 | Phasix Mesh |
| Baxter Healthcare | $312.08 | 2023-2024 | Peri-Strips Dry, Tisseel, Perclot |
| Axogen | $156.08 | 2023 | Avance Nerve Graft |
| Dilon Technologies, INC. | $146.11 | 2024 | Hemoblast Bellows |
| Bard Peripheral Vascular, INC. | $81.64 | 2023 | Phasix Mesh |
| Lightbody Medical Technologies INC | $56.10 | 2025 | |
| Conmed Corporation | $41.67 | 2024 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huy Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.